Gene-environment interactions in chronic obstructive pulmonary disease

International Journal of COPD

Volumn 3, Issue 3, 2008, Pages 491-497

  Molfino, Nestor A ^a   Coyle, Anthony J ^a  

^a MEDIMMUNE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Environment; Genomics; Pathogenesis

Indexed keywords

ALPHA 1 ANTITRYPSIN; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; INTERLEUKIN 13; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; NITROGEN DIOXIDE; OZONE; SULFUR DIOXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

AIR POLLUTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE PREDISPOSITION; DNA METHYLATION; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG FUNCTION; MOLECULAR DYNAMICS; PARTICULATE MATTER; PATHOGENESIS; PHENOTYPE; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AIR POLLUTION; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MODELS, BIOLOGICAL; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SMOKING;

EID: 54949146807     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anthonisen NR, Skeans MA, Wise RA, et al. 2005. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med, 142:233-9.
2. Bailis R, Ezzati M, Kammen DM. 2005. Mortality and greenhouse gas impacts of biomass and petroleum energy futures in Africa. Science, 308:98-103.
3. Barnes PJ, Adcock IM, Ito K. 2005. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J, 25:552-63.
4. Barnes PJ. 2006. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol, 148:245-54.
5. Behrendt CE. 2005. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest, 128:1239-44.
6. Caspi A, Moffitt TE. 2006. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci, 7:583-90.
7. Celli BR, Cote CG, Marin JM, et al. 2004. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350:1005-12.
8. Conrad B, Antonarakis SE. 2007. Gene duplication: a drive for phenotypic diversity and cause of human disease. Annu Rev Genomics Hum Genet, 8:17-35.
9. Cookson WO. 2006. State of the art. Genetics and genomics of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 3:473-5.
10. Dahl M, Tybjaerg-Hansen A, Lange P, et al. 2002. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med, 136:270-9.
11. DeMeo DL, Sandhaus RA, Barker AF, et al. 2007. Determinants of air-flow obstruction in severe alpha 1-antitrypsin deficiency. Thorax, 62:806-13.
12. Donaldson GC, Seemungal TA, Bhowmik A, et al. 2002. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax, 57:847-52.
13. Fisher RA. 1918. The correlation between relatives on the supposition of Mendelian inheritance. Philosophical Transactions of the Royal Society of Edinburgh, 52:399-433.
14. Hutchinson KE, La Chance H, Naiura R, et al. 2002. The DRD4 VNTR polymorphism influences reactivity to smoking cues. J Abnorm Psychol, 111:134-43.
15. Kehrer-Sawatzki H. 2007. What a difference copy number variation makes. Bioessays, 29:311-13.
16. Khoury MJ, Wagener DK. 1995. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet, 56:835-44.
17. Ko FW, Tam WW, Chan DP, et al. 2007. The temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax, 62:780-5.
18. Lipton R, Banerjee A, Dowling KC, et al. 2005. The geography of COPD hospitalization in California. COPD, 2:435-44.
19. Madlung A, Comai L. 2004. The effect of stress on genome regulation and structure. Ann Bot (Lond), 94:481-95.
20. Makris D, Moschandreas J, Damianaki A, et al. 2007. Exacerbations and lung function decline in COPD: New insights in current and ex-smokers. Respir Med, 101:1305-12.
21. Molfino NA. 2004a. Genetics of COPD. Chest, 125:1929-40.
22. Molfino NA. 2004b. Lung function evolution and respiratory symptoms. Arch Bronconeumol, 40:429-30.
23. Molfino NA. 2007a. Current thinking on genetics of chronic obstructive pulmonary disease. Curr Opin Pulm Med, 13:107-13.
24. Molfino NA. 2007b. COPD: what is genes and what is environment? Eur J Clin Inv, 37:37.
25. Naess O, Nafstad P, Aamodt G, et al. 2007. Relation between concentration of air pollution and cause-specific mortality: four-year exposures to nitrogen dioxide and particulate matter pollutants in 470 neighborhoods in Oslo, Norway. Am J Epidemiol, 165:435-43.
26. Pinho RA, Chiesa D, Mezzomo KM, et al. 2007. Oxidative stress in chronic obstructive pulmonary disease patients submitted to a rehabilitation program. Respir Med, 101:1830-5.
27. Segal E, Fondufe-Mittendorf Y, Chen L, et al. 2006. A genomic code for nucleosome positioning. Nature, 442:772-8.
28. 1 in a community population. Chest, 123:1435-40.
29. Silverman EK, Weiss ST, Drazen JM, et al. 2000. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 162:2152-8.
30. Silverman EK. 2006. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc, 3:405-8.
31. Skol AD, Scott LJ, Abecasis GR, et al. 2006. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet, 38:209-13.
32. Stoller JK, Snider GL, Brantly ML, et al. 2005. American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Pneumologie, 59:36-68.
33. Stranger BE, Forrest MS, Dunning M, et al. 2007. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science, 315:848-53.
34. Takabatake N, Shibata Y, Abe S, et al. 2006. A single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 174:875-85.
35. Wallace HM. 2006. A model of gene-gene and gene-environment interactions and its implications for targeting environmental interventions by genotype. Theor Biol Med Model, 3:35.
36. Wolffe AP, Matzke MA. 1999. Epigenetics: regulation through repression. Science, 286:481-6.
37. Ye Y, Zhong X, Zhang H. 2005. A genome-wide tree- and forest-based association analysis of comorbidity of alcoholism and smoking. BMC Genet, 6(suppl 1):S135.